Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Envoy Medical, Inc.

Get SEC filing alerts via email and in your feed for Envoy Medical, Inc.

COCH COCHW

Envoy Medical, Inc.

Envoy Medical, Inc. is a pioneering hearing health company dedicated to transforming the treatment of hearing loss through innovative medical technologies. Its flagship product, the Acclaim CI, is a fully implanted cochlear implant designed to enhance the quality of life for individuals with severe to profound hearing loss. Targeting a significant market opportunity of over $80 billion, Envoy is focused on improving patient access and outcomes while navigating regulatory pathways for FDA approval.
This description was generated via AI from the most recent annual report. Updated 4 months ago.

Latest news & discussion for Envoy Medical, Inc.:

1
1
Envoy Medical, Inc. Envoy Medical Reports $20.8 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 20 days ago | 0 comments

2
1
Envoy Medical, Inc. Envoy Medical Reports Decline in Revenue and Operating Losses Amid Supply Chain Issues and Increased Liabilities

Via official filing (AI summary) | 5 months ago | 0 comments

3
1
Envoy Medical, Inc. Envoy Medical Reports Q2 2024 Financial Results with Increased Revenue and Reduced Net Loss

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
Envoy Medical, Inc. Envoy Medical Reports $59,000 Revenue and $6.3 Million Net Loss in Q1 2024

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
Envoy Medical, Inc. Envoy Medical Reports $29.9 Million Net Loss for Fiscal Year 2023, Revenue Increases 33%

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Envoy Medical, Inc. Envoy Medical Reports Q3 2023 Financial Results with $1.6M Net Income

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Envoy Medical, Inc. Anzu Special Acquisition Corp I Reports $1.14 Million Net Loss for Q2 2023

Via official filing (AI summary) | over 1 year ago | 0 comments

8
1
Envoy Medical, Inc. Anzu Special Acquisition Corp I Reports Q1 2023 Financial Results, Faces Challenges Ahead

Via official filing (AI summary) | almost 2 years ago | 0 comments

9
1
Envoy Medical, Inc. Envoy Medical Reports $19.2 Million Net Income and Plans Business Combination

Via official filing (AI summary) | about 2 years ago | 0 comments

10
1
Envoy Medical, Inc. Anzu Special Acquisition Corp I Reports Q3 2022 Net Income Increase to $5.69 Million

Via official filing (AI summary) | over 2 years ago | 0 comments

11
1
Envoy Medical, Inc. Anzu Special Acquisition Corp I Reports $3.1 Million Net Income in Q2 2022

Via official filing (AI summary) | over 2 years ago | 0 comments

12
1
Envoy Medical, Inc. Anzu Special Acquisition Corp I Reports $12.5 Million Net Income in Q1 2022

Via official filing (AI summary) | almost 3 years ago | 0 comments

13
1
Envoy Medical, Inc. Envoy Medical Reports $484K Net Loss for Fiscal Year 2021, Focuses on IPO and Business Combination

Via official filing (AI summary) | about 3 years ago | 0 comments

14
1
Envoy Medical, Inc. Anzu Special Acquisition Corp I Reports $5.57 Million Net Income in Latest 10-Q Filing

Via official filing (AI summary) | over 3 years ago | 0 comments

15
1
Envoy Medical, Inc. Anzu Special Acquisition Corp I Reports Q2 2021 Financial Results with Net Income of $371,144

Via official filing (AI summary) | over 3 years ago | 0 comments

16
1
Envoy Medical, Inc. Anzu Special Acquisition Corp I Reports $1.47 Million Net Loss Amid IPO Preparations

Via official filing (AI summary) | almost 4 years ago | 0 comments